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Purpose/Objective: The current plan optimization practice 
in radiotherapy involves a time consuming trial-and-error 
loop until the treatment planner finds one single optimal or 
near-optimal plan which is then evaluated by the radiation 
oncologist and the medical physicist (decision makers). In 
contrast, multi-criteria optimization (MCO) aims to avoid the 
iterative optimization loop and to provide alternative choices 
to the decision makers. MCO generates a set of Pareto-
optimal plans which are plans where no criterion can be 
improved without deteriorating another. This set of 
generated decision plans, available for real time navigation 
and decision making, are Pareto optimal in the fluence 
space. The final deliverable plan is created based on the 
navigated plan selected by decision makers, and entails a 
post-optimization step which includes segmentation and a 
final dose calculation. This two-step process could result in 
dosimetric differences between the selected plan and the 
final deliverable one. The purpose of this study was to 
explore the dose difference between navigated and actually 
deliverable plans through the trade-off between two 
evaluation parameters, planning target volume (PTV) under-
dosage and rectum sparing.  
Materials and Methods: Navigated and deliverable VMAT 
plans for five prostate cancer cases were created and 
calculated with RayStation Treatment Planning System. Two-
dimensional Pareto fronts were created corresponding to PTV 
under-dosage vs. rectum sparing. PTV under-dosage was 
evaluated through the volume of PTV receiving less than 95% 
of the prescribed dose and rectum sparing was evaluated 
through the D50% parameter for rectum. In order to minimize 
the effect of the other parameters involved in the treatment 
planning problem and to reduce the multi-dimensionality of 
the problem, we introduced optimization constraints on other 
OARs which ensured minimal dosimetric variations for these 
structures. 
Results: The Pareto front evaluation demonstrated a 
discrepancy for the trade-off parameters between navigated 
and final deliverable plans (see Figure 1). In two of the five 
prostate cases there was an improvement for the deliverable 
plans. For the other cases the discrepancy proved more 
random, resulting in better or worse final plans. Our results 
for prostate cases suggest that the final deliverable plan 
quality may be different from the one that has been used for 
decision making.  
 
Conclusions: The approximation error between the navigated 
and deliverable plans should be estimated and taken into 
consideration in the clinical decision making process when 
MCO is used. 
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Purpose/Objective: Treatment plan evaluation is a clinical 
decision problem with conflicting objectives. In clinical 
practice decision makers perform several clinical judgments 
based on trade-off analysis between tumor coverage and 
healthy tissue sparing in order to conclude if the plan is 
acceptable for treatment. Treatment plan evaluation process 
involves visual search and analysis in a contextually rich 
environment, including delineated structures and isodose 
lines superposed on CT data. Clinical decision making is a 
two-step process including visual analysis and clinical 
reasoning. To our knowledge, there have been no studies 
investigating where decision makers look when they evaluate 
a plan. Additionally, decision makers might not always be 
